马来西亚南部先天性心脏病生存结局:基于注册登记的研究
该研究基于马来西亚柔佛州2006至2020年出生的5728例先天性心脏病(CHD)患儿注册数据,评估从出生至15岁的生存率及相关死亡因素。结果显示总体死亡率为15%,1、5、10、15年生存率分别为88%、85%、84%、83%;需要干预的CHD患儿中10%死于术前或干预前。
要点
- CHD患儿15年生存率约83%,但需干预者术前死亡率达10%。
- 死亡中位年龄为3.7个月,早期死亡风险突出。
- 男性、合并综合征或心外畸形、肺动脉高压、产前诊断及严重病变为独立死亡因素。
核心结论
- 约八成CHD患儿可存活至15岁,但需干预者术前死亡占10%,改善心脏手术与医疗体系对提高生存至关重要。
研究设计与样本
- 基于人群的队列研究,纳入马来西亚柔佛州2006至2020年出生的5728例注册CHD患儿,采用Cox回归和Kaplan-Meier分析。
主要发现
- 5728例中27%病变自愈,5.6%接受舒适治疗,21%无需干预,47%需手术或干预。
- 总体死亡率为15%,死亡中位年龄3.7个月(IQR 0.9-9.8个月)。
- 术前/干预前死亡300例(11%),术后30天内死亡68例(3.2%)。
- 1、5、10、15年估计生存率分别为88%、85%、84%、83%。
- 独立死亡因素包括男性、合并综合征或心外缺陷、肺动脉高压、产前诊断及严重病变。
关键数值与推荐
- 总体死亡率15%,术前/干预前死亡率11%,术后30天内死亡率3.2%。
- 1年生存率88%,5年85%,10年84%,15年83%。
临床怎么用
- 对需干预的CHD患儿应关注术前死亡风险,加强围术期管理。
- 对合并综合征、心外畸形、肺动脉高压、产前诊断及严重病变者应加强随访。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Limited population-based studies are available on the survival of congenital heart disease (CHD) from lower- and middle-income countries. Therefore, we evaluated the survival from birth until 15 years and associated factors for mortality. METHODS: This population-based cohort study included all children with CHD registered in the Pediatric Cardiology Clinical Information System born between 2006 and 2020 in Johor, Malaysia. The mortality rate was calculated, and Cox proportional hazard regression analysis was used to determine factors associated with mortality. The Kaplan-Meier analysis was used to estimate the survival rates at 1, 5, 10 and 15 years. RESULTS: There were 5728 patients with CHD studied, with 1543 (27%) lesions resolved spontaneously, 322 (5.6%) were treated with comfort care, 1189 (21%) required no intervention, and 2674 (47%) needed surgery or intervention. The overall mortality rate was 15%, with a median age of death of 3.7 months (IQR 0.9-9.8 months). Preoperative/intervention death was observed in 300 (11%), and 68 (3.2%) children died within 30 days of surgery or intervention. The overall estimated survival at 1, 5, 10 and 15 years was 88%, 85%, 84% and 83%, respectively. The independent factors associated with mortality were male gender, associated syndrome or extra-cardiac defect, pulmonary hypertension, antenatal diagnosis and severe lesions. CONCLUSIONS: Eight out of 10 patients with CHDs survived up to 15 years of age. However, 10% of CHDs who require intervention die before the procedure. Thus, improving congenital cardiac surgery and enhancing the overall healthcare system are crucial to improve survival.
引用
- Mat Bah MN, Kasim AS, Sapian MH, et al. Survival outcomes for congenital heart disease from Southern Malaysia: results from a congenital heart disease registry. Arch Dis Child. 2024. PMID: 38296612. doi:10.1136/archdischild-2023-326622
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。